Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > ICO will return to 0.05¢

<< Previous

Bullboard Posts

Next >>

Comment by Davidtepperss62on Mar 15, 2019 11:34pm

78 Views

Post# 29494877

RE:ICO will return to 0.05¢

I tell you that it will return to the 0.05 ¢ guarantee of my broker.
Purchase price: five cents per share
Warrants: 25 million share purchase warrants to purchase 25 million shares
exercise price of warrants: 7.5 cents for a period of three years

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"